Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation

In patients with symptomatic COPD, severe/very severe airflow limitation, and a history of one moderate (and no severe) exacerbation, ICS-containing triple therapy significantly reduces exacerbation risk overall versus single or double maintenance therapy http://ow.ly/VgJC30o9pXC

Detalles Bibliográficos
Autores principales: Singh, Dave, Fabbri, Leonardo M., Corradi, Massimo, Georges, George, Guasconi, Alessandro, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853799/
https://www.ncbi.nlm.nih.gov/pubmed/30792343
http://dx.doi.org/10.1183/13993003.00235-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853799/
https://www.ncbi.nlm.nih.gov/pubmed/30792343
http://dx.doi.org/10.1183/13993003.00235-2019

Ejemplares similares